Medacist releases drug auditing and workflow management portal to further tackle drug diversion
ANAHEIM, CA, December 3, 2018 – Medacist, the pioneer and leader in drug diversion analytics, today announced the launch of a new platform designed to further assist hospitals across the country more easily identify and manage cases of drug diversion across their enterprise.
The Genesis analytics platform is built on a new engine quantified through a knowledge base comprised of 20 years of industry exclusive ADS and EMR data from thousands of facilities. The intelligence models derived from this exclusive knowledge base have been built on diversion experience of pattern recognition and confirmed outcomes through machine learning algorithms.
This engine will power an entire new suite of products leading with our first offering: RxAuditor Investigate.
RxAuditor Investigate is a web-based drug auditing portal for all members of an enterprise wide diversion risk team. It provides the team with a pin-pointed outlier list curated by our proprietary risk assurance scoring methodology as well as with a means to conduct a diversion auditing workflow within the application. Our sophisticated visualizations and easy-to-use web application powered by the Genesis engine deliver the healthcare industry the highest level of insight into drug diversion.
Want to learn more about RxAuditor Investigate and the Genesis platform? Come visit us at Booth 1273 or contact us at www.medacist.com!
About Medacist Solutions Group, LLC
Medacist is a privately held company that is committed to the optimization of health care
automation systems by delivering high-quality, cost-effective health care software solutions.
Through the suite of RxAuditor reporting analytics, the company provides critical information
necessary to measure, monitor and manage clinical, economical, and operational automation
metrics in today’s ever-changing healthcare industry. For more information on Medacist, visit
For more information:
Senior Operational Strategist
Phone: 866 633 5393 Ext: 12